Teleflex. has filed a patent for a hemostatic device designed to promote blood clotting using a gauze substrate, clay material, and polyol. The method involves applying the device to a bleeding wound to accelerate clotting. The patent also includes a bandage and hemostatic sponge with similar components. GlobalData’s report on Teleflex gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Teleflex Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Teleflex, Non-invasive physiological monitoring was a key innovation area identified from patents. Teleflex's grant share as of January 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents.

Hemostatic device for accelerating clotting of blood

Source: United States Patent and Trademark Office (USPTO). Credit: Teleflex Inc

A patent application (Publication Number: US20240033398A1) describes a method and system for accelerating clotting in the case of a bleeding wound. The method involves providing a hemostatic device comprising a gauze substrate, clay material, and a binder to bind the clay material to the gauze substrate. The device is then adhered to the skin of the wearer to retain it on or near the bleeding wound. The system includes a flexible substrate to adhere the hemostatic device to the wound, with the gauze substrate being flexible to conform to the shape of the wound and retain it.

The hemostatic device is designed to accelerate clotting by allowing the clay material to come into contact with the bleeding wound. The flexible substrate can be made of non-breathable plastic material and may include a pressure-sensitive adhesive for easy application. The system also includes options for sterilized packaging and the use of a release agent in the hemostatic device. The binder used in the device can be selected from a group of materials including glycerol, chitosan, and calcium alginate. Overall, the method and system aim to provide an efficient and effective way to accelerate clotting in the case of a bleeding wound, with a focus on ease of application and flexibility to conform to different wound shapes.

To know more about GlobalData’s detailed insights on Teleflex, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies